References
- Blomme EAG, Will Y. Toxicology strategies for drug discovery: present and future. Chem Res Toxicol. 2016;29:473–504.
- Worth A, Barroso J, Bremer S, et al. Alternative methods for regulatory toxicology – a state-of-the-art review. Ispra: European Commission. JRC Science and Policy Reports; 2014.
- Daneshian M, Kamp H, Hengstler JG, et al. Highlight report: launch of a large integrated European in vitro toxicology project: EU-ToxRisk. Arch Toxicol. 2016;90:1021–1024.
- Kavlock RJ, Austin CP, Tice RR. Toxicity testing in the 21st century: implications for human health risk assessment. Risk Anal. 2009;29:485–487.
- Ankley GT, Bennett RS, Erickson RJ, et al. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 2011;29:730–741.
- Transtrum MK, Machta BB, Brown KS, et al. Perspective: sloppiness and emergent theories in physics, biology and beyond. J Chem Phys. 2015;143:010901-1-010901-13.
- Urbisch D, Mehling A, Guth K, et al. Assessing skin sensitization hazard in mice and men using non-animal test methods. Regulat Toxicol Pharmacol. 2015;71:337–351.
- Benigni R, Battistelli CL, Bossa C, et al. Alternative toxicity testing: analyses on skin sensitization, Toxcast phases I and II, and carcinogenicity provide indications on how to model mechanisms linked to adverse outcome pathways. J Environ Sci Health C Environ Carcinog Ecotoxicol Revs. 2015;33:422–443.
- Benigni R, Bossa C, Battistelli CL, et al. IARC class 1 and 2 carcinogens are successfully identified by an alternative strategy that detects DNA-reactivity and cell transformation ability of chemicals. Mutat Res. 2013;578:56–61.
- OECD. Fundamental and guiding principles for (Q)SAR analysis of chemical carcinogens with mechanistic considerations. Vol. 224. Paris: OECD. Series on testing and Assessment; 2015.
- Cherkasov A, Muratov EN, Fourches D, et al. QSAR modeling: where have you been? Where are you going to? J Med Chem. 2014;57:4977–5010.
- Benigni R, Bossa C. Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. Chem Revs. 2011;111:2507–2536.
- Sipes NS, Martin MT, Kothiya P, et al. Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays. Chem Res Toxicol. 2013;26:878–895.
- Thomas RS, Black MB, Li L, et al. A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening. Toxicol Scie. 2012;128:398–417.
- Kavlock RJ, Tice RR, Austin CP. A 2012 US Tox21 progress report. In: Seidle T, Spielmann H, editors. Alternative testing strategies, and AXLR8-3 workshop report on a “roadmap to next generation safety testing under horizon 2000”. Berlin: Springer-Verlag; 2012. p. 180–185.